-
Y-27632 ROCK Inhibitor Workflow for YAP/TAZ Assays
2026-09-14
Y-27632 provides a reversible way to test how ROCK-dependent cytoskeletal remodeling influences stress fibers, cell shape, and anchorage-independent growth. This workflow connects practical dose design with the GPR35–Rho–YAP/TAZ findings reported in colorectal cancer models.
-
(S)-Mephenytoin in hiPSC Organoid PK Studies
2026-09-14
Use (S)-Mephenytoin as a mechanistic CYP2C19 substrate to test oxidative drug metabolism in human pluripotent stem cell-derived intestinal models. This workflow connects enzyme kinetics with 2D and 3D organoid formats while addressing solvent effects, diffusion limits, batch variability, and assay qualification.
-
Bafilomycin A1 in Centrosome Studies
2026-09-13
Bafilomycin A1 is a reversible V-ATPase inhibitor that can help researchers distinguish acidification-dependent effects from centrosome proteostasis defects. This article connects lysosomal perturbation with the spatial control of centriolar satellites revealed by recent Kif9 research.
-
Catalpol Assay Strategy for Osteoporosis Models
2026-09-12
Catalpol, also known as Catalpinoside, offers a mechanistically rich framework for osteoporosis and broader disease-model research. This guide translates Sirt6–ERα–FasL evidence into practical assay decisions while placing neuroprotection, stroke, and fibrosis applications in appropriate preclinical context.
-
Chemistry of Silybin: Structure, Separation, and Derivatives
2026-09-11
Křen and colleagues provide a comprehensive chemistry-focused review of silybin, the principal researched flavonolignan from milk thistle extract. Its major contributions are the clarification of silybin A and B stereochemistry, advances in diastereomer separation, and systematic coverage of derivatives designed to modify solubility and biological properties.
-
Cyclosporin A: Assay Workflows and Optimization
2026-09-11
Cyclosporin A supports two complementary research directions: inhibition of T-cell activation through the cyclophilin–calcineurin–NF-AT axis and mitochondrial permeability transition pore inhibition through cyclophilin D. This workflow-focused guide shows how to select concentrations, build controls, compare cyclosporin variants, and troubleshoot cell-based and mitochondrial assays.
-
WP1066: JAK2/STAT3 Inhibitor Workflows
2026-09-10
WP1066 converts JAK2/STAT3 biology into a practical, cell-permeable intervention for cancer signaling, proliferation, apoptosis, and pathway validation. Its use can also extend into macrophage and biomaterial studies when researchers need to test whether STAT3 activation is functionally required.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-09-10
Dimethyloxalylglycine (DMOG), SKU A4506, is a cell-permeable competitive PHD inhibitor used to support pharmacologic hypoxia-inducible factor stabilization under normoxic conditions and related inflammation and infection research. This guide covers solution handling, controls, and QC; the product is for research workflows only, and no directly matched paper evidence or diagnostic or medical use is established for this product entry.
-
Diphenyleneiodonium chloride: Redox Assay Guide
2026-09-09
Diphenyleneiodonium chloride is a versatile tool for separating oxidase-derived ROS from cAMP-linked signaling effects. This practical guide translates citrus canker resistance findings into controlled plant and cell-based workflows, with dosing, controls, and troubleshooting strategies for reproducible oxidative stress research.
-
Açaí Extracts, Hepatocyte Toxicity, and Drug Interactions
2026-09-09
The reference study provides a systematic in vitro assessment of consumer-relevant açaí extracts in human hepatocytes, separating cytotoxicity from induction of major drug-metabolizing enzymes and transporters. Its findings indicate selective, extract-dependent loss of viability but little evidence of CYP450 or transporter induction, supporting a cautious and model-aware approach to botanical–drug interaction research.
-
Budesonide: From Permeability to Translational Insight
2026-09-08
A thought-leadership perspective on using Budesonide to connect glucocorticoid biology, pulmonary permeability, biomimetic chromatography, and translational airway inflammation models.
-
Cl-Amidine: PAD4 Assay Workflows and Use Cases
2026-09-08
Cl-Amidine trifluoroacetate salt enables controlled inhibition of PAD4 for mechanistic studies spanning histone citrullination, inflammatory signaling, cancer research, and sepsis biology. This workflow-focused guide covers assay setup, dose selection, cross-domain interpretation, and troubleshooting without overstating evidence from unrelated disease models.
-
Oridonin Protects Bone Through MAPK/NF-κB and BMP-2/RUNX2
2026-09-07
Jin et al. showed that oridonin counteracts thioacetamide-induced bone damage through two complementary effects: suppressing osteoclastogenesis through MAPK/NF-κB and restoring osteoblast differentiation through BMP-2/RUNX2. The study is notable because it evaluates bone resorption and bone formation within the same experimental framework, while linking oxidative stress and p65 nuclear translocation to the osteoclast response.
-
circRHOBTB3–NONO Axis in Metastatic Prostate Cancer
2026-09-07
The reference study identifies circRHOBTB3 as a downregulated circular RNA that suppresses prostate cancer proliferation and metastasis by retaining NONO in the cytoplasm and limiting MAOA transcription. Its integrated sequencing, molecular, cellular, and animal experiments define a regulatory axis that links circRNA biogenesis to metastatic prostate cancer biology and suggests biomarker and therapeutic research opportunities.
-
CRISPR Screen Identifies F9 in Palbociclib Senescence
2026-09-05
Carpintero-Fernández and colleagues used a genome-wide CRISPR/Cas9 screen to identify coagulation factor IX (F9) as a regulator of the senescence-like response to Palbociclib in breast cancer cells. Independent genetic validation, recombinant-protein experiments, additional cell models, and cancer-dataset analyses indicate that F9 influences CDK4/6 inhibitor-induced proliferation arrest and may help explain variable drug response.